Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edimer Pharmaceuticals Inc.

www.edimerpharma.com

Latest From Edimer Pharmaceuticals Inc.

EspeRare CEO: Proceeds From Dermelix Co-Development Pact To Fund Genetic Pre-Natal Pipeline R&D

The CEO of Swiss not-for-profit foundation EspeRare tells Scrip how she will use funds generated from a co-development pact with Dermelix Biotherapeutics to create novel in utero treatments for rare genetic diseases.

Deals Clinical Trials

Start-Up Execs On The Move, October 2013

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device

Recent Financings Of Private Companies, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors.

BioPharmaceutical Medical Device

Financings of the Fortnight: Getting Comfortable In Genes

Investor confidence in the potential for gene therapy is renewing, witness recent VC backing of GenSight and Audentes and bluebird bio’s IPO. Plus news on financings by Edimer, aTyr Pharma, Dicerna, and BioMotiv.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Edimer Pharmaceuticals Inc.
  • Senior Management
  • Neil Kirby, PhD, Pres. & CEO
    Kenneth Huttner, MD, PhD, VP, Clin. Dev.
  • Contact Info
  • Edimer Pharmaceuticals Inc.
    Phone: (517) 758-4300
    55 Cambridge Pkwy.
    Ste. 102W
    Cambridge, MA 02142
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register